These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 19875571)

  • 1. White-coat hypertension should not be treated in subjects with diabetes.
    Bursztyn M; Ben-Dov IZ
    Diabetes Care; 2009 Nov; 32 Suppl 2(Suppl 2):S310-3. PubMed ID: 19875571
    [No Abstract]   [Full Text] [Related]  

  • 2. Should white-coat hypertension in diabetes be treated? Pro.
    Mancia G; Sega R; Bombelli M; Quarti-Trevano F; Facchetti R; Grassi G
    Diabetes Care; 2009 Nov; 32 Suppl 2(Suppl 2):S305-9. PubMed ID: 19875570
    [No Abstract]   [Full Text] [Related]  

  • 3. White coat hypertension in NIDDM patients with and without incipient and overt diabetic nephropathy.
    Nielsen FS; Gaede P; Vedel P; Pedersen O; Parving HH
    Diabetes Care; 1997 May; 20(5):859-63. PubMed ID: 9135956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Is prevalence of the "white coat effect" correlated with a high risk of late diabetic complications in type 2 diabetic patients?].
    Mozdzan M; Ruxer J; Barański M; Roszczyk N; Markuszewski L
    Ann Acad Med Stetin; 2008; 54(1):65-9; discussion 69. PubMed ID: 19127812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Should we treat prehypertension in diabetes? What are the cons?
    Grossman E
    Diabetes Care; 2009 Nov; 32 Suppl 2(Suppl 2):S280-3. PubMed ID: 19875565
    [No Abstract]   [Full Text] [Related]  

  • 6. Should 24-h ambulatory blood pressure monitoring be done in every patient with diabetes?
    Parati G; Bilo G
    Diabetes Care; 2009 Nov; 32 Suppl 2(Suppl 2):S298-304. PubMed ID: 19875569
    [No Abstract]   [Full Text] [Related]  

  • 7. Smoking amplifies cardiovascular risk in patients with hypertension and diabetes.
    Fagard RH
    Diabetes Care; 2009 Nov; 32 Suppl 2(Suppl 2):S429-31. PubMed ID: 19875595
    [No Abstract]   [Full Text] [Related]  

  • 8. Predictors for the white coat effect in general practice patients with suspected and treated hypertension.
    Lindbaek M; Sandvik E; Liodden K; Mjell J; Ravnsborg-Gjertsen K
    Br J Gen Pract; 2003 Oct; 53(495):790-3. PubMed ID: 14601355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Masked hypertension and white-coat hypertension: therapeutic navigation between scylla and charybdis.
    Messerli FH; Cotiga D
    J Am Coll Cardiol; 2005 Aug; 46(3):516-7. PubMed ID: 16053967
    [No Abstract]   [Full Text] [Related]  

  • 10. Prognosis of "masked" hypertension and "white-coat" hypertension detected by 24-h ambulatory blood pressure monitoring 10-year follow-up from the Ohasama study.
    Ohkubo T; Kikuya M; Metoki H; Asayama K; Obara T; Hashimoto J; Totsune K; Hoshi H; Satoh H; Imai Y
    J Am Coll Cardiol; 2005 Aug; 46(3):508-15. PubMed ID: 16053966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [White coat hypertension].
    Lantelme P; Milon H
    Arch Mal Coeur Vaiss; 2000 Dec; 93(12):1534-40. PubMed ID: 11211449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. White coat effect in treated hypertensive patients: sex differences.
    Myers MG; Reeves RA
    J Hum Hypertens; 1995 Sep; 9(9):729-33. PubMed ID: 8551486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and predictors of white-coat response in patients with treated hypertension.
    MacDonald MB; Laing GP; Wilson MP; Wilson TW
    CMAJ; 1999 Aug; 161(3):265-9. PubMed ID: 10463047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systolic hypertension and the white coat phenomenon.
    Myers MG
    Am J Hypertens; 1996 Sep; 9(9):938-40. PubMed ID: 8879353
    [No Abstract]   [Full Text] [Related]  

  • 15. Is white-coat hypertension innocent or detrimental?
    Mansoor GA; White WB
    Blood Press Monit; 1999 Oct; 4(5):241-7. PubMed ID: 10547645
    [No Abstract]   [Full Text] [Related]  

  • 16. Psychological constructs associated with emotional blood pressure response and white coat phenomenon.
    Crippa G; Bertoletti P; Bettinardi O; Calandra G; Carrara GC
    Ann Ital Med Int; 2000; 15(4):250-4. PubMed ID: 11202625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The unique vulnerability of diabetic subjects to hypertensive injury.
    Williams B
    J Hum Hypertens; 1999 Apr; 13 Suppl 2():S3-8; discussion S25-8. PubMed ID: 10335851
    [No Abstract]   [Full Text] [Related]  

  • 18. Determinants of the white-coat effect in hypertensive subjects.
    Mansoor GA; McCabe EJ; White WB
    J Hum Hypertens; 1996 Feb; 10(2):87-92. PubMed ID: 8867561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular prognosis of sustained and white-coat hypertension in patients with type 2 diabetes mellitus.
    Eguchi K; Hoshide S; Ishikawa J; Ishikawa S; Pickering TG; Gerin W; Ogedegbe G; Schwartz JE; Shimada K; Kario K
    Blood Press Monit; 2008 Feb; 13(1):15-20. PubMed ID: 18199919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic value of strategy for the detection of white coat hypertension based on ambulatory and home blood pressure monitoring.
    Stergiou GS; Alamara CV; Skeva II; Mountokalakis TD
    J Hum Hypertens; 2004 Feb; 18(2):85-9. PubMed ID: 14730322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.